14 days of Premium, free.
Every scanner with live hit rates + the Market Pulse risk flag that tells you when to get defensive. No card required.
Start trial →
Tradestie Institutional Equity Comparison Engine · Market Close Nov 20, 2026
REPX vs VET: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
REPX Overall Winner
6-Pillar Tally: REPX 3 – 3 VET
Matrix Metrics: REPX 8 – 2 VET
As of Nov 20, 2026, Riley Exploration Permian, Inc. (REPX) is the stronger overall head-to-head candidate over Vermilion Energy Inc. (VET) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). REPX carries a Unified Composite Score of 76.5/100 (STRONG BUY) at $41.04 (3.4x Forward P/E, 45.7% operating margin), whereas VET carries 71.1/100 (BUY) at $10.25 (17.4x Forward P/E, -0.7% operating margin).
Technical & Structure Timing Caution: REPX trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 39.3); meanwhile VET is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on REPX vs VET. Trailing 12-month operating profitability (REPX 45.7% vs VET -0.7%) and valuation multiples (REPX 3.4x vs VET 17.4x Forward P/E) are benchmarked directly in Pillar 4 below.
Competes within the Oil & Gas E&P value chain with $909.4M market capitalization and 45.7% operating margin.
OpEx & R&D Reinvestment28.0% of Rev ($162M)
90D Engineering Disclosures0 Published
VET Moat ProfileCyclical / Execution-Driven Positioning
Oil & Gas E&P Operator
Competes within the Oil & Gas E&P value chain with $1.6B market capitalization and -0.7% operating margin.
OpEx & R&D Reinvestment64.7% of Rev ($1.27B)
90D Engineering Disclosures0 Published
Investor FAQ REPX vs VET Key Questions & Quantitative Answers
As of Nov 20, 2026, Riley Exploration Permian, Inc. (REPX) is the stronger overall head-to-head candidate over Vermilion Energy Inc. (VET) in the Tradestie Institutional Equity Comparison Engine, winning 8–2 core matrix metrics and 3–3 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). REPX carries a Unified Composite Score of 76.5/100 (STRONG BUY) at $41.04 (3.4x Forward P/E, 45.7% operating margin), whereas VET carries 71.1/100 (BUY) at $10.25 (17.4x Forward P/E, -0.7% operating margin). Technical & Structure Timing Caution: REPX trades in a Neutral technical trend (UNCLASSIFIED options phase, RSI 39.3); meanwhile VET is in a short-term Weinstein Markdown pullback below its falling 50-day moving average (RSI 33.5). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
REPX leads the Growth & Scale pillar: REPX posts +88.3% YoY revenue growth and +185.4% YoY earnings growth on $578M TTM revenue (73.7% gross margin, 45.7% operating margin), compared with VET at +30.4% YoY revenue growth and -94.9% YoY earnings growth on $1.97B TTM revenue (64.0% gross margin, -0.7% operating margin). On trailing 12-month operating scale, REPX generates $578M in USD-normalized revenue versus $1.97B for VET. In operating R&D and SG&A reinvestment, REPX deploys 28.0% of Rev ($162M) (0 90-day corporate R&D disclosures) versus 64.7% of Rev ($1.27B) (0 disclosures) for VET.
REPX screens cheaper on headline valuation multiples. REPX trades at 3.4x Forward P/E, 8.7x Trailing P/E, 2.84x PEG, and 1.6x EV/Revenue (64.9% EBITDA margin), whereas VET trades at 17.4x Forward P/E, 17.4x Trailing P/E, 3.58x PEG, and 1.4x EV/Revenue (66.5% FCF margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against REPX (16.8% ROE) versus VET (-20.1% ROE) capital efficiency.
In options market volatility and institutional positioning, REPX carries 74.5% implied volatility (100th %ile, Extreme (>80th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.65β · 62% Vol realized risk). By comparison, VET carries 46.5% implied volatility (23rd %ile, Compressed (<25th %ile)), a 0.30x (Call-Skewed) Put/Call open-interest ratio, NEUTRAL on-balance volume, and sits in a CONSOLIDATION options structure phase (-0.77β · 61% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 20, 2026. For educational research only; not investment advice.